WID: 58396173- 9831-42A1-813C- 9D2559BR5EeSdAa
TCGA- VL- ASN‘I- 01A- PR

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICIImjl
||||||||III|IIIII I|I|I IIII|II|II IIIIIIIIIIIIIII III
|II|||I|IIIIIIIIII|I|I|I ||||II|IIIIIII|IIII|I|||IIIIIIIIIII

PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADICAL PROSTATECTOMY:
TUMOR PROCUREMENT:
HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA
HISTOLOGIC GRADE (PRIMARY PA‘I'I'ERN+SECONDARY PATTERN = GLEASON SCORE):
5+4=9
TERTIARY PATTERN NOT PRESENT
PERCENTAGE OF DIFFERENT GLEASON PATTERNS
1:_%
2:___%
3:___%
4:___5%
5:_95%
TUMOR LOCATION
APEX
MID
BASE IQID do -5
ANTERIOR '
RIGHT

LEFT WW.MOS 5740/5

POSTERIOR

EIGHHT 54h; : QM NOS (Hal. ‘7

EXTRA-PROSTATIC EXTENSION 91‘) 5/19” ‘7’
PRESENT

NON-FOCAL
SITE 0F EXT RA-PROSTATIC EXTENSION
APEX
MID
BASE
ANTERIOR
RIGHT
LEFT
POSTERIOR
RIGHT
LEFI'
SEMINAL VESICAL INVASION
PRESENT
BOTH
SURGICAL MARGINS
INVOLVED BY INVASIVE CARCINOMA
APEX
MID
BASE
ANTERIOR
RIGHT
LEFI‘
POSTERIOR
RIGHT
LEFT
NATURE OF POSITIVE MARGINS
INDETERMINATE
EXTENT OF POSITIVE MARGINS
MULTIFOCAL

MILLIMETRIC EXTENT OF POSITIVE MARGINS: _15 MM
GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS
5 + 5 = 10
LYMPHOVASCULAR INVASION
PRESENT
PERINEURAL INVASION
NOT REPORTED
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _70%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
RIGHT PELVIC OBTURATOR
NUMBER OF NODES INDENTIFIED: _10__
NUMBER OF NODES INVOLVED BY METASTASIS: _5__
LEFT PELVIC OBTURATOR
NUMBER OF NODES IDENTIFIED: _9_
NUMBER OF NODES INVOLVED BY METASTASIS: _6__
DIAMETER 0F LARGEST LYMPH NODE METASTASIS: _NOT REPORTED
ADDITIONAL PATHOLOGIC FINDINGS '
NONE REPORTED
PATHOLOGICAL STAGING
pT3b
pN1
pMX

[III
Diagnosis Discrepancy

Prlmarv Tum or Site Dlscrepancy
HIPAA Discrepancy

u!- ﬂ/J’lla’l‘} Ill“: IM/
I I

 

 

 

     
   
 
  
   

 
 

Dual/S

  

   

Prior Mllignlncy History

Inldals

onuus Primary
. « . . .

.I teReVIewed: / J

  

